Literature DB >> 6642076

A new in vitro melanophore bioassay for MSH using tail-fins of Xenopus tadpoles.

P N de Graan, R Molenaar, F C van de Veerdonk.   

Abstract

A new in vitro melanophore system is described, which employs pieces from the ventral tail-fin of Xenopus laevis tadpoles. Tail-fin melanophores in vitro retain the ability to disperse their pigment in darkness and to reaggregate it upon illumination. In the light, alpha-MSH, cAMP, dibutyryl-cAMP and theophylline induce a concentration-dependent pigment dispersion. The log dose-response curve obtained with alpha-MSH is sigmoidal with a linear portion between 0.5 and 2.0 ng alpha-MSH/ml. In this range, the log dose-response curve can be used as the standard curve in a bioassay for melanotropic activity, applying either the melanophore index (assay I) or a photometric transmittance measurement (assay II) for the quantification of the melanophore response. To prevent interference from the light/darkness response, light of 400-500 nm (to which the melanophores are most sensitive) was used during the assay. Both assays show high precision (lambda I = 0.13, lambda II = 0.11). Several peptides derived from alpha-MSH were tested for their melanotropic activity. The in vitro Xenopus melanophore system offers unique properties for the study of alpha-MSH action: (1) the melanophore system is uncontaminated with other chromatophores; (2) to date it is the only system suitable for photoaffinity labelling of alpha-MSH receptors; and (3) the melanophore receptor requirements differ from those of Rana.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6642076     DOI: 10.1016/0303-7207(83)90088-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  An Anolis skin melanophore assay suitable for photoaffinity labeling studies with alpha-MSH.

Authors:  A N Eberle; J Girard
Journal:  Experientia       Date:  1985-05-15

2.  Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy.

Authors:  Marshall D Winget; Mark D Ericson; Katie T Freeman; Carrie Haskell-Luevano
Journal:  ACS Med Chem Lett       Date:  2019-07-02       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.